332 related articles for article (PubMed ID: 24937591)
1. Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro.
Conforti A; Scarsella M; Starc N; Giorda E; Biagini S; Proia A; Carsetti R; Locatelli F; Bernardo ME
Stem Cells Dev; 2014 Nov; 23(21):2591-9. PubMed ID: 24937591
[TBL] [Abstract][Full Text] [Related]
2. A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity.
Herzig MC; Delavan CP; Jensen KJ; Cantu C; Montgomery RK; Christy BA; Cap AP; Bynum JA
J Immunol Methods; 2021 Jan; 488():112915. PubMed ID: 33212091
[TBL] [Abstract][Full Text] [Related]
3. Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes.
Zanone MM; Favaro E; Miceli I; Grassi G; Camussi E; Caorsi C; Amoroso A; Giovarelli M; Perin PC; Camussi G
J Clin Endocrinol Metab; 2010 Aug; 95(8):3788-97. PubMed ID: 20466784
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory effects of human amniotic membrane-derived mesenchymal stem cells.
Kang JW; Koo HC; Hwang SY; Kang SK; Ra JC; Lee MH; Park YH
J Vet Sci; 2012 Mar; 13(1):23-31. PubMed ID: 22437532
[TBL] [Abstract][Full Text] [Related]
5. Interactions of human mesenchymal stromal cells with peripheral blood mononuclear cells in a Mitogenic proliferation assay.
Herzig MC; Christy BA; Montgomery RK; Delavan CP; Jensen KJ; Lovelace SE; Cantu C; Salgado CL; Cap AP; Bynum JA
J Immunol Methods; 2021 May; 492():113000. PubMed ID: 33609532
[TBL] [Abstract][Full Text] [Related]
6. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts.
Melief SM; Zwaginga JJ; Fibbe WE; Roelofs H
Stem Cells Transl Med; 2013 Jun; 2(6):455-63. PubMed ID: 23694810
[TBL] [Abstract][Full Text] [Related]
7. Human olfactory mucosa multipotent mesenchymal stromal cells promote survival, proliferation, and differentiation of human hematopoietic cells.
Diaz-Solano D; Wittig O; Ayala-Grosso C; Pieruzzini R; Cardier JE
Stem Cells Dev; 2012 Nov; 21(17):3187-96. PubMed ID: 22471939
[TBL] [Abstract][Full Text] [Related]
8. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.
DelaRosa O; Lombardo E; Beraza A; Mancheño-Corvo P; Ramirez C; Menta R; Rico L; Camarillo E; García L; Abad JL; Trigueros C; Delgado M; Büscher D
Tissue Eng Part A; 2009 Oct; 15(10):2795-806. PubMed ID: 19231921
[TBL] [Abstract][Full Text] [Related]
9. Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes.
Favaro E; Carpanetto A; Lamorte S; Fusco A; Caorsi C; Deregibus MC; Bruno S; Amoroso A; Giovarelli M; Porta M; Perin PC; Tetta C; Camussi G; Zanone MM
Diabetologia; 2014 Aug; 57(8):1664-73. PubMed ID: 24838680
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells suppress B-cell terminal differentiation.
Asari S; Itakura S; Ferreri K; Liu CP; Kuroda Y; Kandeel F; Mullen Y
Exp Hematol; 2009 May; 37(5):604-15. PubMed ID: 19375651
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells microvesicles stabilize endothelial barrier function partly mediated by hepatocyte growth factor (HGF).
Wang H; Zheng R; Chen Q; Shao J; Yu J; Hu S
Stem Cell Res Ther; 2017 Sep; 8(1):211. PubMed ID: 28969681
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of microvesicles from mesenchymal stem cells.
Mohammadi MR; Riazifar M; Pone EJ; Yeri A; Van Keuren-Jensen K; Lässer C; Lotvall J; Zhao W
Methods; 2020 May; 177():50-57. PubMed ID: 31669353
[TBL] [Abstract][Full Text] [Related]
13. Lysis and phenotypic modulation of mesenchymal stromal cells upon blood contact triggers anti-inflammatory skewing of the peripheral innate immune repertoire.
Davies LC; Queckbörner S; Jylhä CE; Andrén AT; Forshell TZP; Blanc KL
Cytotherapy; 2023 Sep; 25(9):956-966. PubMed ID: 37354149
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-17A- or tumor necrosis factor α-mediated increase in proliferation of T cells cocultured with synovium-derived mesenchymal stem cells in rheumatoid arthritis.
Zhang Z; Ding Y; Li W; Song B; Yang R
Arthritis Res Ther; 2013 Oct; 15(5):R169. PubMed ID: 24286220
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.
Ribeiro A; Laranjeira P; Mendes S; Velada I; Leite C; Andrade P; Santos F; Henriques A; Grãos M; Cardoso CM; Martinho A; Pais M; da Silva CL; Cabral J; Trindade H; Paiva A
Stem Cell Res Ther; 2013 Oct; 4(5):125. PubMed ID: 24406104
[TBL] [Abstract][Full Text] [Related]
16. Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells.
Gieseke F; Böhringer J; Bussolari R; Dominici M; Handgretinger R; Müller I
Blood; 2010 Nov; 116(19):3770-9. PubMed ID: 20644118
[TBL] [Abstract][Full Text] [Related]
17. Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions.
Najar M; Raicevic G; Id Boufker H; Stamatopoulos B; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Exp Hematol; 2010 Oct; 38(10):922-32. PubMed ID: 20570633
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic Chondrogenic Mesenchymal Stromal Cells Alter Helper T Cell Subsets in CD4+ Memory T Cells.
Kiernan CH; Asmawidjaja PS; Fahy N; Witte-Bouma J; Wolvius EB; Brama PAJ; Lubberts E; Farrell E
Tissue Eng Part A; 2020 May; 26(9-10):490-502. PubMed ID: 31797740
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes.
Zhou C; Yang B; Tian Y; Jiao H; Zheng W; Wang J; Guan F
Cell Immunol; 2011; 272(1):33-8. PubMed ID: 22004796
[TBL] [Abstract][Full Text] [Related]
20. Placenta-derived multipotent mesenchymal stromal cells: a promising potential cell-based therapy for canine inflammatory brain disease.
Amorim RM; Clark KC; Walker NJ; Kumar P; Herout K; Borjesson DL; Wang A
Stem Cell Res Ther; 2020 Jul; 11(1):304. PubMed ID: 32698861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
